Carol R. Lizak - Oct 8, 2024 Form 4 Insider Report for Jaguar Health, Inc. (JAGX)

Role: Chief Financial Officer
Signature: /s/ Carol R, Carol R. Lizak
Stock symbol: JAGX
Transactions as of: Oct 8, 2024
Transactions value $: $0
Form type: 4
Date filed: 10/10/2024, 09:58 PM
Previous filing: May 21, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	JAGX	Common Stock	Award	$0	+4.28K	+25176.47%	$0.00	4.3K	Oct 8, 2024	Direct	F1, F2, F3, F4
holding	JAGX	Common Stock						1	Oct 8, 2024	See Footnote	F4, F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	JAGX	Stock option (right to buy)	Award	$0	+34.2K		$0.00	34.2K	Oct 8, 2024	Common Stock	34.2K	$1.29	Direct	F1, F2, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Granted pursuant to the issuer's 2014 Stock Incentive Plan.
F2	The option and restricted stock unit grants were approved by the issuer's board of directors on October 8, 2024.
F3	Each restricted stock unit represents a contingent right to receive one share of the issuer's voting common stock. The restricted stock units vest in three equal annual installments beginning on October 8, 2025. Vested shares will be delivered to the reporting person on the vesting date or dates provided in the grant notice.
F4	On May 23, 2024, the issuer effected a 60-for-1 reverse stock split of the issued and outstanding shares of its voting common stock (the " Reverse Stock Split). Upon effectiveness of the Reverse Stock Split, every 60 shares of voting common stock was automatically converted into one share of voting common stock.
F5	The options will vest ratably on a monthly basis over 36 months from the grant date, so long as the executive remains employed by the issuer.
F6	Securities held directly by the Peter & Carol Lizak Revocable Trust. Ms. Lizak, by virtue of her position as a co-trustee and beneficiary of such trust and her sharing of voting and investment control over the securities held by the trust with her spouse, may be deemed to beneficially own the securities held by the Peter & Carol Lizak Trust for purposes of Section 16.